Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
11 participants
OBSERVATIONAL
2008-01-01
2016-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The purpose of this study is to identify the risk factors of these infections.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Bacillus Cereus Invasive Infections in Preterm Neonates Hospitalized in French Hospitals
NCT06973174
Staphylococcus Haemolyticus in the Neonatal Intensive Care Unit of CHSD in 2023: Analysis and Trends
NCT07013864
Treatment of Enterococcus Faecalis Bacterem
NCT07299539
Late-onset Sepsis in Term and Pre-term Neonates and Infants up to 3 Months of Age
NCT05856227
SEPSIS: L. Plantarum Trial
NCT05180201
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Bacillus Cereus is the most common members of the genus Bacillus. Only few reports studied these systemic infections in premature neonates. In order to identify the risk factors for severe Bacillus Species infections, we studied retrospectively eleven cases of these infections in our NICU and reviewed series and report cases in literature.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Premature neonates infected with bacillus Species
The investigators studied retrospectively eleven cases of these infections in our NICU and reviewed series and report cases in literature.
Ways to prevent these infections.
The purpose of this database is to describe the pathogenicity of this germ, the incriminated modes of contamination.
The collaborators studied the factors of poor prognosis and propose ways to prevent these infections.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ways to prevent these infections.
The purpose of this database is to describe the pathogenicity of this germ, the incriminated modes of contamination.
The collaborators studied the factors of poor prognosis and propose ways to prevent these infections.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* cases of Bacillus species meningitis
* with significant change in clinical status
* Bacillus Species is the only organism isolated
Exclusion Criteria
28 Days
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hôpital NOVO
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mohamed Amine YANGUI
Role: PRINCIPAL_INVESTIGATOR
Hôpital NOVO
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CHRD1715
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.